THC — Tenet Healthcare Corporation

Is THC overbought or oversold? Here is the current MarketMoodz read.

Healthcare · Medical Care Facilities

Oversold As of October 3, 2026

Tenet Healthcare Corporation (THC) currently reads Oversold on the MarketMoodz overbought/oversold meter, as of October 3, 2026. The Healthcare name (Medical Care Facilities) last closed at $258.62. The rating moved from Neutral to Oversold on September 29, 2026.

See all oversold Healthcare stocks →

AI analysis

Tenet Healthcare Corporation (THC) combines stable acute-care demand with sensitivity to elective-procedure volumes and reimbursement dynamics. Liquidity and revenue-cycle execution are key determinants of near-term free cash flow, while labor costs and Medicare Advantage reimbursement trends will shape margins. Near-term catalysts include normalization of elective volumes and improved collections; key threats are sustained payer pressure, staffing-cost escalation and regulatory shifts that could compress profitability.

Key factors

  • Tenet Healthcare Corporation (THC) operates a diversified hospital and outpatient network with steady acute-care demand, giving it defensive revenue exposure during risk-off market environments
  • Recent volume trends in elective procedures and ambulatory services drive near-term revenue sensitivity; recovery in elective care supports revenue upside
  • Balance sheet and liquidity profile: manageable leverage relative to peers but sensitive to working capital and reimbursement timing (cash flow dependent)
  • Revenue cycle performance and collections (including Conifer-related operations) materially impact margin and free cash flow generation
  • Payor mix exposure to Medicare Advantage and commercial contracts creates both stable volume and reimbursement-pressure risk as plans expand $0-premium/benefit offerings
  • Labor, wage inflation and staffing shortages remain key margin headwinds and can compress operating margins if not controlled
  • Regulatory and policy environment (Medicare negotiation, reimbursement changes) and broader health-care cost pressures create medium-term uncertainty

Risks

  • Downward reimbursement pressure from Medicare Advantage competition and payer rate negotiations reducing per-case revenue
  • Prolonged labor cost inflation, nurse staffing shortages and contract renewals that increase operating expenses
  • A slowdown in elective procedures or outpatient volumes due to macro uncertainty or patient behavior changes, reducing top-line growth
  • Regulatory/policy shocks (Medicare payment reforms, state-level rate changes) or unfavorable Medicare drug/pricing politics that indirectly affect hospital economics
  • Execution risk on revenue cycle management, collections and integration of ambulatory assets leading to lower-than-expected cash flow
  • Exposure to legal and compliance/regulatory actions that could drive one-time charges or reputational damage
  • Supply-chain disruptions or capital allocation missteps that delay cost-saving initiatives or required facility investments

See today's live rating, score and targets

Members see the live hourly rating for THC — the numeric AI score plus targets and entry zones — while this public page updates nightly.

Start the 14-day trial

This page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.